Intensive chemotherapy with or without gemtuzumab ozogamicin in patients with NPM1-mutated acute myeloid leukaemia (AMLSG 09–09): a randomised, open-label, multicentre, phase 3 trial
Resource Type
Article
Authors
Döhner, Hartmut ; Weber, Daniela ; Krzykalla, Julia ; Fiedler, Walter ; Kühn, Michael W.M. ; Schroeder, Thomas ; Mayer, Karin ; Lübbert, Michael ; Wattad, Mohammad ; Götze, Katharina ; Fransecky, Lars ; Koller, Elisabeth ; Wulf, Gerald ; Schleicher, Jan ; Ringhoffer, Mark ; Greil, Richard ; Hertenstein, Bernd ; Krauter, Jürgen ; Martens, Uwe M. ; Nachbaur, David ; Samra, Maisun Abu ; Machherndl-Spandl, Sigrid ; Basara, Nadezda ; Leis, Claudia ; Schrade, Anika ; Kapp-Schwoerer, Silke ; Cocciardi, Sibylle ; Bullinger, Lars ; Thol, Felicitas ; Heuser, Michael ; Paschka, Peter ; Gaidzik, Verena I. ; Saadati, Maral ; Benner, Axel ; Schlenk, Richard F. ; Döhner, Konstanze ; Ganser, Arnold ; Kühn, Michael W M ; Wattad, Mohammed ; Martens, Uwe M ; Gaidzik, Verena I ; Schlenk, Richard F
Source
In The Lancet Haematology July 2023 10(7):e495-e509
Subject
Primary Research Articles
Language
ISSN
2352-3026